Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mode of action of Moviprep: impact on intestinal fluid distribution and colonic microbiota
2010-021879-85Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Aug 2010
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of macrogol in None (2 arms), sponsored by University of Nottingham. Started Aug 2010; status: completed.
02
Drugs
macrogol
Beyond the preview
Go deeper on 2010-021879-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021879-85.